Composition, in particular pharmaceutical composition, in the form of a fixed dosage (
solid dosage form) for sucking and / or chewing, preferably for sucking, in particular lozenge, preferably for use in the prophylactic and / or therapeutic topical (local) treatment of inflammatory diseases of the mouth and
throat, wherein the composition contains an effective, in particular pharmaceutically and / or therapeutically effective, amount of an
active ingredient preferably suitable and / or effective for the topical (local) treatment of inflammatory diseases of the mouth and
throat, in particular with
antiseptic and / or
antimicrobial properties, preferably with antibacterial and / or antiviral and / or
antifungal properties, wherein the
active ingredient is incorporated and / or embedded in a
solid matrix, wherein the composition, in particular the
solid dosage form and / or the matrix, releases the
active ingredient upon topical (local) application and / or use, preferably by sucking and / or chewing, preferably by sucking, in the oral and
pharyngeal cavity; wherein the active ingredient is octenidine, in particular in the form of a pharmaceutically compatible and / or physiologically acceptable salt or ester, preferably in the form of a pharmaceutically compatible and / or physiologically acceptable salt, particularly preferably octenidine dihydrochloride; and wherein the composition, in particular the solid
dosage form and / or the matrix, furthermore and / or additionally contains at least one further ingredient (a) and / or (b), in particular (a) and (b), wherein the at least one further ingredient (a) and / or (b) is selected from the group of (a)
Flavor modulators, in particular selected from the group of the following components (i), (ii) and / or (iii): (i) Bitter (taste) masking agents, in particular selected from the group consisting of
bitter taste receptor antagonists, preferably 4-(2,2,3-trimethylcyclopentyl)butanoic acid, and saponins, preferably glycyrrhizic acid (
glycyrrhizin) and its salts or esters and / or glycyrrhetinic acid (
glycyrrhetin) and its salts or esters, complexing agents, in particular cyclodextrins, and combinations or mixtures thereof, (ii) Bitter substances, in particular coffee extract and / or tea extract and / or their respective bitter substances, preferably coffee extract and / or its bitter substances, (iii) preferably natural or nature-identical (
aroma) oils and / or essential oils, in particular with
antiseptic and / or
antimicrobial properties, preferably with antibacterial,
antifungal and / or antiviral properties, in particular selected from the group of anise oils, in particular star anise oil, peppermint oil,
eucalyptus oil,
lavender oil,
tea tree oil,
chamomile oil, clove oil,
rosemary oil, caraway oil,
cinnamon oil, sage oil and
fennel oil, as well as combinations or mixtures thereof; in particular wherein the ingredient (a) and / or the
flavor modulator comprises a combination of at least two different components (i), (ii) and / or (iii), preferably a combination of components (i), (ii) and (iii); (b) Acidulants, in particular
saliva-stimulating and / or
flavor-enhancing acidulants, preferably acidulants authorized under pharmaceutical and / or food law and / or acidulants authorized as pharmaceutical additives and / or food additives, in particular selected from the group of
tartaric acid and its salts, in particular
sodium tartrate,
sodium potassium tartrate (Rochelle salt) and
calcium tartrate,
citric acid and its salts, metatartaric acid,
fumaric acid,
ascorbic acid,
phosphoric acid and its salts, stannous
chloride, in particular
tin(II)
chloride,
malic acid,
lactic acid,
adipic acid,
succinic acid and other pharmaceutically compatible and / or physiologically acceptable organic acids and their salts, as well as their combinations or mixtures.